Pharmacology of venotomic drugs: Current data on the mode of action and therapeutic targets;Pharmacologie des médicaments veinotoniques: Données actuelles sur leur mode d'action et les cibles thérapeutiques

Angeiologie

Volumn 52, Issue 5, 2000, Pages 71-77

  Boisseau, M R ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYL; COLLAGEN; DAFLON; DIHYDROERGOTAMINE; DIOSMIN; DOBESILATE CALCIUM; FLAVONOID; GINKGO BILOBA EXTRACT; GINKOR FORT; HEPTAMINOL; HEPTAMINOL ADENOSINE PHOSPHATE; MELILOTUS EXTRACT; NAFTAZONE; OXYGEN RADICAL; PROCYANIDOL OLIGOMER; PROSTAGLANDIN E2; PYCNOGENOL; RUSCUS ACULEATUS EXTRACT; RUTOSIDE; TROXERUTIN; VEINOBIASE; VEINOSTASE; VELITEN;

CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; DRUG MECHANISM; FIBRINOLYSIS; HUMAN; PLETHYSMOGRAPHY; SHORT SURVEY;

EID: 0034491777     PISSN: 00033049     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (34)

1. Recommandations et références médicales: Veinotropes. Insuffisance veineuse chronique des membres inférieurs
2. Veinotropes
3. Visualisation des vasa vasorums par doppler puissance dans les veines normales et variqueuses
4. Etiologies et mécanismes des varices: Réalités et perspectives
5. Mesure de la pression en oxygène dans la paroi des veines normales et variqueuses
6. Laser doppler flux in normal and varicose long saphenous vein wall
7. Hemorrheology in clinical practice. Applications in an in vitro study of troxerutin
8. Fibrinolysis and hemorheology in chronic venous insufficiency: A double blind study of troxerutin efficiency
9. Fibrinolyse et hémorhéotogy dans l'insuffisance veineuse chronique
10. The cause of venous ulceration
11. Fibrinolytic activity and calf pump failure
12. Hemorheological disturbances in venous insufficiency after induced stasis
13. Hemorheological factors in the pathophysiology of venous disease
14. Clinical effectiveness of venotonic drugs: A meta analysis
15. Traitements médicamenteux de l'IVC: Évaluation pharmacoclinique
16. Meta-analysis of hydroxymethylrutosides in the treatment of chronic venous insufficiency
17. Pharmacologic aspects of a phlebotropic drug in CVI-associated edema
18. Pharmacodynamics of troxerutine in patients with CVI: Corelations with plasma drug levels
19. Three treatments for chronic venous insufficieny: Escin, hydroxyethylrutoside and Daflon
20. Relief Study: First consolidated European data. Reflux assesment and quality of life improvement with micronized flavonoids
21. Increasing erythrocyte aggregability with the progressive grades of CVI: Importance and mechanisms
22. The management of patients with venous disease
23. Traitement médical de l'insuffisance veineuse chronique
24. Médicaments de l'insuffisance veinolymphatique
25. Vers une prise en charge globale de l'insuffisance veineuse chronique: Aspects cliniques
26. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of CVI
27. Endothelial activation in patients with chronic venous diseases
28. White cell accumulation in the dependent legs of patients with venous hypertension: A possible mechanism for trophic changes in the skin
29. Patients with venous stasis ulceration have increascd monocyte platelet aggregation
30. Therapeutic efficacy of flavonoids in oedema following reperfusion on acutely ischaemic legs
31. Evaluation of haemorheological and microcirculatory disturbances in CVI: Activity of Daflon 500 mg
32. Effect of oral micronized flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: A pilot study